Skip to content
Screener

Palvella Therapeutics PVLA Q2 2026 earnings

Reported August 4, 2026 · Before market open

EPS-$1.52Miss by $0.35
EPS estimate-$1.17

Next report

Nov 10, 2026 (in 2 months)
Revenue estimate$16.7K
EPS estimate-$1.74

FAQ

When did Palvella Therapeutics report Q2 2026 earnings?
Palvella Therapeutics (PVLA) reported Q2 2026 earnings on August 4, 2026 before market open.
What were Palvella Therapeutics's Q2 2026 revenue and EPS?
Palvella Therapeutics reported eps of $-1.52 for Q2 2026.
Did Palvella Therapeutics beat estimates in Q2 2026?
EPS missed the consensus estimate of $-1.17 by $0.35.
How did Palvella Therapeutics's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 76.7% from $-0.86.
Where can I find Palvella Therapeutics's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-331556) and the 10-Q periodic report (0001193125-26-331574) directly on SEC EDGAR. The filing index links above go to sec.gov.